Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

In the high-stakes world of pharmaceutical manufcturing, where regulatory compliance meets razor-thin margins and patient safety, one industry leader is redefining what Lean transformation means in ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...

Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.

A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...

Haitao Li, chair of the supply chain analytics department at the University of Missouri-St. Louis, says that the Trump ...